Characterizing the heterogeneity of neurodegenerative diseases through EEG normative modeling

dc.contributor.authorTabbal, Judie
dc.contributor.authorEbadi, Aida
dc.contributor.authorMheich, Ahmad
dc.contributor.authorKabbara, Aya
dc.contributor.authorGüntekin, Bahar
dc.contributor.authorYener, Görsev
dc.contributor.authorPaban, Veronique
dc.contributor.authorGschwandtner, Ute
dc.contributor.authorFuhr, Peter
dc.contributor.authorVerin, Marc
dc.contributor.authorBabiloni, Claudio
dc.contributor.authorAllouch, Sahar
dc.contributor.authorHassan, Mahmoud
dc.date.accessioned2026-09-23T14:39:01Z
dc.date.available2026-09-23T14:39:01Z
dc.date.issued2025-12
dc.descriptionPublisher Copyright: © The Author(s) 2025.en
dc.description.abstractNeurodegenerative diseases like Parkinson’s (PD) and Alzheimer’s (AD) exhibit considerable heterogeneity of functional brain features within patients, complicating diagnosis and treatment. Here, we use electroencephalography (EEG) and normative modeling to investigate neurophysiological mechanisms underpinning this heterogeneity. Resting-state EEG data from 14 clinical units included healthy adults (n = 499) and patients with PD (n = 237) and AD (n = 197), aged over 40. Spectral and source connectivity analyses provided features for normative modeling, revealing significant, frequency-dependent EEG deviations with high heterogeneity in PD and AD. Around 30% of patients exhibited spectral deviations, while ~80% showed functional source connectivity deviations. Notably, the spatial overlap of deviant features did not exceed 60% for spectral and 25% for connectivity analysis. Furthermore, patient-specific deviations correlated with clinical measures, with greater deviations linked to worse UPDRS for PD (⍴ = 0.24, p = 0.025) and MMSE for AD (⍴ = −0.26, p = 0.01). These results suggest that EEG deviations could enrich individualized clinical assessment in Precision Neurology.en
dc.description.versionPeer revieweden
dc.format.extent1744727
dc.format.extent
dc.identifier.citationTabbal, J, Ebadi, A, Mheich, A, Kabbara, A, Güntekin, B, Yener, G, Paban, V, Gschwandtner, U, Fuhr, P, Verin, M, Babiloni, C, Allouch, S & Hassan, M 2025, 'Characterizing the heterogeneity of neurodegenerative diseases through EEG normative modeling', npj Parkinson's Disease, vol. 11, no. 1, 117. https://doi.org/10.1038/s41531-025-00957-6en
dc.identifier.doi10.1038/s41531-025-00957-6
dc.identifier.issn2373-8057
dc.identifier.other251042670
dc.identifier.other730031e3-c803-4eec-9c92-22c746d4a6e0
dc.identifier.other105004434940
dc.identifier.urihttps://hdl.handle.net/20.500.11815/8326
dc.language.isoen
dc.relation.ispartofseriesnpj Parkinson's Disease; 11(1)en
dc.relation.urlhttps://www.scopus.com/pages/publications/105004434940en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectNeurologyen
dc.subjectNeurology (clinical)en
dc.subjectCellular and Molecular Neuroscienceen
dc.titleCharacterizing the heterogeneity of neurodegenerative diseases through EEG normative modelingen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
s41531-025-00957-6.pdf
Stærð:
1.66 MB
Snið:
Adobe Portable Document Format